Application Note: WB: 0.1-0.5μg/ml. IHC-P: 0.5-1μg/ml. ELISA: 1-5μg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 18
Form: Liquid
Buffer (with preservative): 4mg Trehalose, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg sodium azide.
Concentration: 0.5 mg/ml (Please refer to the vial label for the specific concentration.)
Background: IL31, which is made principally by activated Th2-type T cells, interacts with a heterodimeric receptor consisting of IL31RA (MIM 609510) and OSMR (MIM 601743) that is constitutively expressed on epithelial cells and keratinocytes. IL31 may be involved in the promotion of allergic skin disorders and in regulating other allergic diseases, such as asthma (Dillon et al., 2004 [PubMed 15184896]).[supplied by OMIM, Mar 2008]
Uniprot ID: Q6EBC2
Antigen Species: Human
Immunogen: E.coli-derived human IL-31 recombinant protein (Position: S24-T164).
Purification: Purified by antigen-affinity chromatography
Conjugation: Unconjugated
Full Name: interleukin 31
English
Deutsch
